A Study of Darunavir in Combination With Cobicistat or Ritonavir, and Dabigatran Etexilate in Healthy Participants
Condition: Healthy Interventions: Drug: Dabigatran Etexilate; Drug: DRV/COBI; Drug: Ritonavir; Drug: Darunavir Sponsor: Janssen Research & Development, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 23, 2019 Category: Research Source Type: clinical trials
Characteristics and Outcomes of Patients Who Received Etravirine and/or Darunavir
Condition: HIV/AIDS Intervention: Sponsors: Elizabeth Glaser Pediatric AIDS Foundation; Janssen, LP Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 11, 2019 Category: Research Source Type: clinical trials
Inflammation and Co-Infections in D ²EFT
Conditions: HIV-infection/Aids; Human Herpesvirus 4 Infections; Cytomegalovirus Infections; Human Herpesvirus 8 Infection; Human Papilloma Virus Interventions: Drug: NRTIs; Drug: Darunavir; Drug: Ritonavir; Drug: Dolutegravir Sponsors: Kirby Institute; Frederick National Laboratory for Cancer Research; UNITAID; National Institute of Allergy and Infectious Diseases (NIAID); ViiV Healthcare; Janssen Pharmaceutica Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 3, 2019 Category: Research Source Type: clinical trials
